Importantly, treatment of USP22-null breast cancer cells did not further reduce the frequency of breast cancer stem cells (Fig. 5D and s5F), supporting the high specificity of this USP22-specific small molecule inhibitor. The gene discussed is USP22; the disease is breast cancer.